Image

AChild - Austrian Children With Hearing Impairment - Longitudinal Database

Recruiting
- 72 years of age
Both
Phase N/A

Powered by AI

Overview

There is high variability in outcomes in children with hearing impairment. Existing literature focus mainly on subpopulations (children with hearing aids, children with CI) and is usually not epidemiological. Often children with additional needs (intellectual disability, visual impairment, autism spectrum disorder, complex syndromes) are excluded from the studies. This subgroup of children makes up around 1/3 of the population of children with hearing impairment.

What factors contribute to the unexplained variance in language development in children with hearing loss? (including children with additional needs, multilingual) There is a lack of European epidemiological studies that evaluate the effects of Newborn Hearing Screening and early intervention.

Description

Aims
  • to collect population based data on children born in Upper Austria with a significant hearing impairment and to describe this population in detail regarding audiological, etiological (including geno- and phenotypical correlations), neurodevelopmentally, psychological, psychiatrically and linguistically with a special interest is in children with additional needs
  • collecting child development outcomes (language, communication, psychosocial) and family outcomes (quality of life, stress)
  • to investigate possible effects of the Newborn Hearing Screening, early intervention and specific parent behaviors targeted in early intervention
  • collecting developmental trajectories of the total sample and subgroups of the sample (particularly audiological, etiological and cognitive). This data should help identify red flags
  • investigating predictors of developmental trajectories regarding the child and the intervention (e.g. time and
    Hypothesis
  • It is expected that .2% of the total population of preschool children have a sensorineural hearing loss (bilateral and unilateral)
  • a significantly higher prevalence of intellectual disabilities (up to 20%), visual impairment, autism spectrum disorder and motor impairment
  • it is expected that for at least 50% of the children, there is a genetic explanation for the hearing impairment and 30% out of them are expected to be syndromal
  • it is expected that there is a higher proportion of children with psycho-social problems (especially peer problems and behavioral-/emotional problems)
  • Due to a change in the environmental conditions over the past two decades, better child outcomes, compared to previous ones are expected. Nevertheless around 30-50% of the children are expected to not be reaching their nonverbal cognitive potential.
  • expected intervention effects, particularly for provision with and use of hearing technology family-child interaction self-efficacy and wellbeing of the family regulated media use

Eligibility

Inclusion Criteria:

  • with significant sensorineural hearing impairment or permanent congenital conductive deafness; profound hearing impairment above frequency of 0.5, 1, 2 and 4 kHz of ≥ 25 dB
  • unilateral or bilateral
  • diagnosed before the age of 6 years
  • including children with multiple disabilities
  • including children with another language than German (including sign language)
  • including children with auditory neuropathy spectrum disorder (ANS)
  • including children with behavioral problems and psychiatric disorders

Exclusion Criteria:

  • children who were older than 6 years when they were diagnosed
  • who's families do not agree to participate in the study
  • with temporary conductive deafness

Study details

Hearing Impaired Children

NCT04317456

Johannes Kepler University of Linz

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.